Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hale

Showing results (351-360 of 418) with videos related to

Pageof 42
Sort By:
Occupational and Environmental Medicine|September 20, 2005
Rapidly progressive coal workers' pneumoconiosis in the United States: geographic clustering and other factorsV C dos S Antao, E L Petsonk, L Z Sokolow, et al.
Lancet (London, England)|September 30, 2008
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trialAlan Garber, Robert Henry, Robert Ratner, et al.
NPJ Digital Medicine|July 16, 2019
Use of user-centered design to create a smartphone application for patient-reported outcomes in atopic dermatitisLia E Gracey, Shiyi Zan, Joseph Gracz, et al.
Infectious Agents and Cancer|December 8, 2006
Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control studyA Berrington de González, M I Urban, F Sitas, et al.
British Journal of Cancer|June 28, 2002
Risk factors for oesophageal, lung, oral and laryngeal cancers in black South AfricansR Pacella-Norman, M I Urban, F Sitas, et al.
Animals : an Open Access Journal From MDPI|February 15, 2022
An Updated Review of Hypotheses Regarding Bat Attraction to Wind TurbinesEmma E Guest, Brittany F Stamps, Nevin D Durish, et al.
International Forum of Allergy & Rhinology|July 16, 2024
A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRSSamuel J M Hale, Christian A Lux, James E Willoughby, et al.
Scientific Reports|May 21, 2025
Dose-dependent impact of tixagevimab-cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individualsDaniela Dluzynski, Paddy Ssentongo, Cory M Hale, et al.
Biophysical Journal|July 17, 2007
Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migrationJerry S H Lee, Christopher M Hale, Porntula Panorchan, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Pageof 42

Showing results (351-360 of 418) with videos related to

Sort By:
Pageof 42
Occupational and Environmental Medicine|September 20, 2005
Rapidly progressive coal workers' pneumoconiosis in the United States: geographic clustering and other factorsV C dos S Antao, E L Petsonk, L Z Sokolow, et al.
Lancet (London, England)|September 30, 2008
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trialAlan Garber, Robert Henry, Robert Ratner, et al.
NPJ Digital Medicine|July 16, 2019
Use of user-centered design to create a smartphone application for patient-reported outcomes in atopic dermatitisLia E Gracey, Shiyi Zan, Joseph Gracz, et al.
Infectious Agents and Cancer|December 8, 2006
Antibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control studyA Berrington de González, M I Urban, F Sitas, et al.
British Journal of Cancer|June 28, 2002
Risk factors for oesophageal, lung, oral and laryngeal cancers in black South AfricansR Pacella-Norman, M I Urban, F Sitas, et al.
Animals : an Open Access Journal From MDPI|February 15, 2022
An Updated Review of Hypotheses Regarding Bat Attraction to Wind TurbinesEmma E Guest, Brittany F Stamps, Nevin D Durish, et al.
International Forum of Allergy & Rhinology|July 16, 2024
A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRSSamuel J M Hale, Christian A Lux, James E Willoughby, et al.
Scientific Reports|May 21, 2025
Dose-dependent impact of tixagevimab-cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individualsDaniela Dluzynski, Paddy Ssentongo, Cory M Hale, et al.
Biophysical Journal|July 17, 2007
Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migrationJerry S H Lee, Christopher M Hale, Porntula Panorchan, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Pageof 42